Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for its Coronary Intravascular Lithotripsy (IVL) System to ...

Abbott has announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) ...

Mammograms, with the help of artificial intelligence (AI) models, may reveal much more than cancer, according to a study ...

Mammograms, with the help of artificial intelligence (AI) models, may reveal much more than cancer, according to a study being presented at the American College of Cardiology’s Annual Scientific ...

Abbott (NYSE: ABT) received FDA investigational device exemption (IDE) approval for its coronary intravascular lithotripsy ...

Mammograms, with the help of artificial intelligence (AI) models, may reveal much more than cancer, according to a study being presented at the ...

Johnson & Johnson and Boston Scientific have also recently made moves to sell their own coronary intravascular lithotripsy ...

A novel therapeutic showed significant promise in slowing aortic valve calcification, potentially extending time until or eliminating need for transcatheter or surgical intervention for stenosis, ...

The Javelin IVL catheter "has the ability to transform the way that physicians are able to treat patients,” Shockwave CMO Dr.

Researchers from Osaka University, Japan claim to have found a cellular 'master switch' which can reverse the process of ageing.

Chronic kidney disease, also called End Stage Renal Failure, describes the gradual loss of kidney function. The kidneys filter waste and excess fluids from the blood, which is then excreted ...